PD27-01 DEFINING SYNAPTOTAGMIN-1 AS THE RECEPTOR FOR BOTULINUM NEUROTOXIN B IN THE BLADDER

INTRODUCTION AND OBJECTIVE:Neurogenic and idiopathic detrusor overactivity (DO) is currently treated with onabotulinumtoxin A (BoNT/A) as third line therapy. In cases of treatment failure, alternat...